Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients

Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Letters Source Type: research